Directors Resign as 23andMe Privatization Efforts Sputter
Board memebers quit as founder Anne Wojcicki works to come up with an acceptable financial offer to purchase its remaining shares and take the company private.
23andMe directors resign as CEO seeks to take genetic-testing company private
All of 23andMe's independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.
23andMe just lost all its board members in a mass resignation
All 23andMe independent board members resigned en masse Tuesday following a monthslong battle over CEO Anne Wojcicki’s plans to take the company private.
23andMe Board Resigns in New Blow to DNA-Testing Company
All seven independent directors of DNA-testing company 23andMe resigned, following a protracted negotiation with CEO Anne Wojcicki over her plan to take the company private.
Turmoil strikes 23andMe as board members resign in dispute with founder
Seven independent members of the company’s board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s expressed intention to take the company private, “no such proposal is forthcoming.
23andMe independent board resigns in feud over CEO Anne Wojcicki’s plan to take company private
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the company private since April, proposed to acquire all outstanding shares of 23andMe not owned by her or her affiliates for $0.40 per share, in July.
23andMe CEO Anne Wojcicki ‘surprised and disappointed' by board resignations: Read the memo
All seven independent directors of 23andMe resigned from the company's board Tuesday, a move that CEO Anne Wojcicki said left her "surprised and disappointed," according to a memo to employees. Wojcicki, who co-founded 23andMe in 2006, said she remains committed to taking the company private.
23andMe directors resign as the CEO of the genetic-testing company seeks to take it private
All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company
Independent directors resign from 23andMe board after opposing move to privatize
The seven independent members of the board of personal genomics company 23andMe quit Tuesday amid opposition to CEO Anne Wojcicki’s plan to take the company private.
23andMe's CEO Anne Wojcicki 'Disappointed' at Board Shakeup as All Seven Independent Directors Resign
All seven independent directors of 23andMe resigned from the board, citing disagreements with CEO Anne Wojcicki regarding the company’s strategic direction. Wojcicki expressed "disappointment" in the resignations but reaffirmed her commitment to taking the genetic-testing company private despite a rejected proposal in July.
This Genomics Company Says It's Considering Acquiring 23andMe
The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...
What happened to 23andMe?
The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...
Read the memo 23andMe's cofounder sent to staff after the entire board quit
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits
(Bloomberg) -- 23andMe Holding Co. co-founder and Chief Executive Officer Anne Wojcicki told employees that she remains ...